Extraintestinal manifestations of inflammatory bowel disease: Do they influence treatment and outcome?

Figure 1 Associations of the four major inflammatory extraintestinal manifestations in 169 of 480 Crohn’s disease patients.

Figure 2 Cumulative probability of having a repetition of the same inflammatory extraintestinal manifestations.

Figure 3 Distribution of inflammatory extraintestinal manifestations according to the Vienna classification in 169 Crohn’s disease patients.

Figure 4 Severe lesions of erythema nodosum treated with infliximab.

Figure 5 Pyoderma gangrenosum before, during and after treatment with infliximab.

Figure 6 Aphthous ulcers in the buccal mucosa and on the tongue.

Figure 7 Ankylosing spondylitis and uveitis in the same patient.

Figure 8 ERCP showing sclerosing cholangitis and endoscopic view of carcinoma of the colon observed in the same patient.